EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Evaluating Biomarkers as Tools for Early Detection and Prognosis of Heart Failure: A Comprehensive Review

Moza A Alzaabi, Amin Abdelsalam, Majid Alhammadi, Hasan Bani Hani, Ali Almheiri, Nadya Al Matrooshi, Khaled Al Zaman

Cardiac Failure Review · 03.06.2024 · 10

DOI: 10.15420/cfr.2023.24 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiac Failure Review, online erschienen am 03.06.2024. Verfasst von Moza A Alzaabi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cardiothoracic Surgery, Heart, Vascular & Thoracic Institute, Cleveland Clinic Abu Dhabi Abu Dhabi, United Arab Emirates. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is a high prevalence of heart failure (HF) worldwide, which has significant consequences for healthcare costs, patient death and quality of life. Therefore, there has been much focus on finding and using biomarkers for early diagnosis, prognostication and therapy of HF. This overview of the research presents a thorough examination of the current state of HF biomarkers and their many uses. Their function in diagnosing HF, gauging its severity and monitoring its response to therapy are all discussed. Particularly promising in HF diagnosis and risk stratification are the cardiac-specific biomarkers, B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide. Markers of oxidative stress, extracellular matrix, renal function, inflammation and cardiac peptides have shown promise in evaluating HF severity and prognosis. MicroRNAs and insulin-like growth factor are two emerging biomarkers that have shown potential in helping with HF diagnosis and prognosis.

Schlagwörter

Stichwörter der Autor:innen

Biomarkerbiomarkersheart failureprognosis

Autor:innen und Institutionen

  • Cardiothoracic Surgery, Heart, Vascular & Thoracic Institute, Cleveland Clinic Abu Dhabi Abu Dhabi, United Arab Emirates.
  • Department of Cardiology, Al Qassemi Hospital Sharjah, United Arab Emirates.
  • College of Medicine, University of Sharjah Sharjah, United Arab Emirates.

Zitieren

APA

Alzaabi, M. A., Abdelsalam, A., Alhammadi, M., Bani Hani, H., Almheiri, A., Al Matrooshi, N., & Al Zaman, K. (2024). Evaluating Biomarkers as Tools for Early Detection and Prognosis of Heart Failure: A Comprehensive Review. Cardiac Failure Review, 10. https://doi.org/10.15420/cfr.2023.24

Vancouver

Alzaabi MA, Abdelsalam A, Alhammadi M, Bani Hani H, Almheiri A, Al Matrooshi N, et al. Evaluating Biomarkers as Tools for Early Detection and Prognosis of Heart Failure: A Comprehensive Review. Cardiac Failure Review. 2024;10. doi:10.15420/cfr.2023.24

BibTeX
@article{Alzaabi2024,
  author = {Alzaabi, Moza A and Abdelsalam, Amin and Alhammadi, Majid and Bani Hani, Hasan and Almheiri, Ali and Al Matrooshi, Nadya and Al Zaman, Khaled},
  title = {Evaluating Biomarkers as Tools for Early Detection and Prognosis of Heart Failure: A Comprehensive Review},
  journal = {Cardiac Failure Review},
  year = {2024},
  volume = {10},
  doi = {10.15420/cfr.2023.24}
}
Kostenlos starten →